Cost-effectiveness of artificial intelligence for screening colonoscopy: a modelling study.

Journal: The Lancet. Digital health
Published Date:

Abstract

BACKGROUND: Artificial intelligence (AI) tools increase detection of precancerous polyps during colonoscopy and might contribute to long-term colorectal cancer prevention. The aim of the study was to investigate the incremental effect of the implementation of AI detection tools in screening colonoscopy on colorectal cancer incidence and mortality, and the cost-effectiveness of such tools.

Authors

  • Miguel Areia
    RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto, Porto, Portugal; Gastroenterology Department, Portuguese Oncology Institute of Coimbra, Coimbra, Portugal.
  • Yuichi Mori
    Clinical Effectiveness Research Group, Institute of Health and Society, University of Oslo, and Department of Transplantation Medicine Oslo University Hospital, Oslo, Norway; Digestive Disease Center, Showa University Northern Yokohama Hospital, Yokohama, Japan. Electronic address: ibusiginjp@gmail.com.
  • Loredana Correale
    Endoscopy Unit, Humanitas Clinical Center - IRCCS, Rozzano, Italy.
  • Alessandro Repici
    Digestive Endoscopy Unit, Division of Gastroenterology, Humanitas Clinical and Research Center IRCCS, Rozzano, 20089, Italy; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, MI, Italy.
  • Michael Bretthauer
    Clinical Effectiveness Research Group, Institute of Health and Society, University of Oslo, and Department of Transplantation Medicine Oslo University Hospital, Oslo, Norway.
  • Prateek Sharma
    Department of Gastroenterology and Hepatology, Kansas City VA Medical Center, Kansas City, Kansas, USA.
  • Filipe Taveira
    Gastroenterology Department, Portuguese Oncology Institute of Coimbra, Coimbra, Portugal.
  • Marco Spadaccini
    Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.
  • Giulio Antonelli
    Gastroenterology Unit, Nuovo Regina Margherita Hospital, Rome, Italy.
  • Alanna Ebigbo
    Medizinische Klinik III, Klinikum Augsburg, Germany.
  • Shin-Ei Kudo
    Digestive Disease Center, Showa University Northern Yokohama Hospital, Tsuzuki-ku, Yokohama, 224-8503, Japan.
  • Julia Arribas
    RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto, Porto, Portugal.
  • Ishita Barua
    Clinical Effectiveness Research Group, Institute of Health and Society, University of Oslo, and Department of Transplantation Medicine Oslo University Hospital, Oslo, Norway.
  • Michal F Kaminski
    Departments of Cancer Prevention and Oncological Gastroenterology, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland; Department of Gastroenterology, Hepatology, and Oncology, Medical Center for Postgraduate Education, Warsaw, Poland; Institute of Health and Society, University of Oslo, Oslo, Norway.
  • Helmut Messmann
    Medizinische Klinik III, Klinikum Augsburg, Germany.
  • Douglas K Rex
    Division of Gastroenterology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Mario Dinis-Ribeiro
    Department of Gastroenterology, Portuguese Oncology Institute of Porto, Porto, Portugal.
  • Cesare Hassan
    Gastroenterology Unit, Nuovo Regina Margherita Hospital, Rome, Italy.